Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Oncology · Anaplastic Thyroid Carcinoma

Anaplastic Thyroid Carcinoma (ATC) Urgent Action Plan

At a Glance

Anaplastic Thyroid Carcinoma (ATC) is an aggressive medical emergency requiring immediate treatment at a specialized high-volume center. Rapid BRAF mutation testing is critical to determine if targeted therapies can quickly shrink the tumor to enable further care.

Anaplastic Thyroid Carcinoma (ATC) is not like other thyroid cancers. It is an extremely aggressive malignancy that grows with incredible speed [1][2]. Because it can double in size in just a matter of days, ATC is considered a medical emergency [2].

The moment ATC is suspected, time is the most critical factor. Decisions that used to take weeks must now be made in days [3]. While this diagnosis is frightening, the landscape has changed: new targeted therapies and “fast-track” protocols at high-volume centers are now saving lives that were previously considered untreatable [3][4].

Why You Must Go to a High-Volume Center

Because ATC is so rare and fast-moving, most local hospitals do not have the specialized infrastructure to treat it effectively. You need a multidisciplinary team—including expert surgeons, oncologists, radiation specialists, and pathologists—who work together daily [3][1]. High-volume centers often use a FAST protocol (Facilitating Anaplastic Thyroid Cancer Specialized Treatment) to bypass standard hospital wait times and start treatment immediately [3].

The Priority: Rapid BRAF Testing

The single most important piece of information for your treatment is whether your tumor has a BRAF V600E mutation [3][5].

  • BRAF-Mutated ATC: About 25-50% of ATC cases have this mutation [6]. For these patients, a combination of targeted drugs (like dabrafenib and trametinib) can cause the tumor to shrink rapidly, often within days [6][7].
  • BRAF-Wild Type (No Mutation): If the mutation is not present, doctors use other strategies, including intensive chemotherapy, immunotherapy, or clinical trials [8][5].

The Modern “Multimodal” Approach

Treatment for ATC is no longer just “one thing.” It is a combination of therapies used in rapid succession [3][4]:

  1. Systemic Therapy First: Many centers now start with targeted therapy or immunotherapy to shrink the tumor before attempting surgery. This is called neoadjuvant therapy [3][7].
  2. Immunotherapy: Drugs like pembrolizumab (PD-1 inhibitors) help your own immune system recognize and attack the cancer. These are often used alongside targeted drugs to make the treatment more effective [4][9].
  3. Surgery: If the drugs shrink the tumor enough to make surgery safe, a surgeon will remove as much of the cancer as possible while protecting your airway and vocal cords [3].
  4. Radiation: Intensive radiation therapy is often used after surgery or alongside chemotherapy to keep the cancer from returning locally [10][11].

Protecting Your Airway (CRITICAL WARNING)

Because ATC grows in the neck, it can quickly press on the windpipe (trachea) or the nerves that control your vocal cords. Sudden hoarseness or voice changes can be an early warning sign of nerve involvement [12][3].

If you notice a harsh, high-pitched whistling sound when you breathe (stridor) or a sudden increase in difficulty breathing, this is a sign of an immediate airway obstruction [12]. Call 911 or go to the nearest emergency room immediately. Do not wait to contact your oncology clinic or wait for a scheduled appointment. Your medical team will monitor your airway closely during scheduled visits, but airway emergencies at home require immediate, emergency intervention [12][3].

Common questions in this guide

Why do I need to go to a high-volume center for Anaplastic Thyroid Carcinoma?
Because ATC is extremely rare and fast-growing, local hospitals often lack the specialized infrastructure required. High-volume centers have multidisciplinary teams that use expedited protocols to bypass standard wait times and begin treatment immediately.
What is a BRAF test and why is it urgently needed?
A BRAF test checks if your tumor carries the BRAF V600E mutation, which is present in up to half of ATC cases. If you have this mutation, doctors can prescribe specific targeted drugs that can cause the tumor to shrink rapidly, often within days.
Will I have surgery right away for ATC?
Modern ATC treatment relies on a multimodal approach. Doctors frequently use targeted therapies or immunotherapy first to shrink the tumor as much as possible. If the tumor shrinks enough, surgery may then be performed safely, followed by intensive radiation.
What should I do if I hear a whistling sound when I breathe?
A high-pitched whistling sound when you breathe is called stridor. This, along with sudden hoarseness or worsening shortness of breath, indicates the tumor may be blocking your windpipe. You must call 911 or go to the nearest emergency room immediately.
What are my options if I am BRAF-wild type (no mutation)?
If your tumor does not have the BRAF mutation, your multidisciplinary team will utilize other intensive strategies. These may include combinations of chemotherapy, immunotherapy drugs that help your body fight the cancer, or enrollment in clinical trials.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How quickly can we get the results of a BRAF mutation test, and can we start targeted therapy the moment they are available?
  2. 2.Does this hospital have a dedicated multidisciplinary team (FAST protocol) that specializes in treating Anaplastic Thyroid Carcinoma?
  3. 3.Is my tumor currently considered 'resectable' (removable by surgery), or should we use targeted therapy first to shrink it?
  4. 4.If I am BRAF-wild type, what are my options for clinical trials or immunotherapy combinations?
  5. 5.What is our plan if the tumor begins to interfere with my breathing or swallowing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Anaplastic Thyroid Carcinoma: An Update.

    Jannin A, Escande A, Al Ghuzlan A, et al.

    Cancers 2022; (14(4)) doi:10.3390/cancers14041061.

    PMID: 35205809
  2. 2

    Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.

    Roche AM, Fedewa SA, Shi LL, Chen AY

    Cancer 2018; (124(8)):1780-1790 doi:10.1002/cncr.31252.

    PMID: 29409119
  3. 3

    Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.

    Hamidi S, Dadu R, Zafereo ME, et al.

    JAMA oncology 2024; (10(9)):1264-1271 doi:10.1001/jamaoncol.2024.2133.

    PMID: 38990526
  4. 4

    Anticancer drug therapy for anaplastic thyroid cancer.

    Kiyota N, Koyama T, Sugitani I

    European thyroid journal 2025; (14(2)).

    PMID: 40163699
  5. 5

    Histological features of BRAF V600E-mutant anaplastic thyroid carcinoma.

    Chen TY, Lorch JH, Wong KS, Barletta JA

    Histopathology 2020; (77(2)):314-320 doi:10.1111/his.14144.

    PMID: 32428249
  6. 6

    Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

    Subbiah V, Kreitman RJ, Wainberg ZA, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(1)):7-13 doi:10.1200/JCO.2017.73.6785.

    PMID: 29072975
  7. 7

    Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature.

    Arıkan R, Telli TA, Demircan NC, et al.

    Current problems in cancer 2021; (45(2)):100668 doi:10.1016/j.currproblcancer.2020.100668.

    PMID: 33127167
  8. 8

    Remarkable Response to Chemo-immunotherapy In Anaplastic Thyroid Cancer.

    Carosi F, Nigro MC, Siepe G, et al.

    JCEM case reports 2025; (3(9)):luaf160 doi:10.1210/jcemcr/luaf160.

    PMID: 40727481
  9. 9

    Modern Therapeutic Approaches in Anaplastic Thyroid Cancer: A Meta-Analytic Review of Randomised and Single Arm Studies on Efficacy and Survival.

    Tunio MA, Hinder D, Emery B, et al.

    Cancers 2025; (17(5)) doi:10.3390/cancers17050777.

    PMID: 40075624
  10. 10

    An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients.

    Huang NS, Shi X, Lei BW, et al.

    International journal of endocrinology 2019; (2019()):8428547 doi:10.1155/2019/8428547.

    PMID: 30915116
  11. 11

    Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer.

    Li W, Li Y, Li J, Pang H

    Technology in cancer research & treatment 2023; (22()):15330338231169870 doi:10.1177/15330338231169870.

    PMID: 37122242
  12. 12

    The Role of Tracheostomy in Anaplastic Thyroid Carcinoma.

    Xu J, Liao Z, Li JJ, et al.

    World journal of oncology 2015; (6(1)):262-264 doi:10.14740/wjon899w.

    PMID: 29147413

This page is for informational purposes only and does not replace emergency medical advice. Anaplastic Thyroid Carcinoma is a medical emergency; always seek immediate care from a specialized multidisciplinary team or an emergency room if breathing becomes difficult.

Get notified when new evidence is published on Rare thyroid carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.